MD study, maximum tolerated dose; 4T1 metastasis study effect of bewley cmpd on 4T1 breast cancer metastasis
Ended Purchase Order Awarded
- Contract number
- HHSN267200801024P
- Awardee
-
Comparative Biosciences, Inc. UEI NJLNAFJ1A715
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Sunnyvale, CA 94085, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN267200801024P?
HHSN267200801024P was awarded to Comparative Biosciences, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 8, 2008.
How much is contract HHSN267200801024P worth?
The government has obligated $24,000 on HHSN267200801024P.
Was contract HHSN267200801024P competed?
The extent of competition for HHSN267200801024P was not competed. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award